roflumilast 0.3 % Topical Foam

RxCUI: 2671682
RxNorm name: roflumilast 0.3 % Topical Foam
Display name: roflumilast 0.3 % Topical Foam
Full name: roflumilast 0.3 % Topical Foam
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ZORYVE	ROFLUMILAST	Arcutis Biotherapeutics, Inc.	f9e0b4a9-a227-4947-b00c-41fb18d16589	2026-06-22	Warnings, Adverse reactions	Exact identifier rxcui: 2671682

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
f9e0b4a9-a227-4947-b00c-41fb18d16589	roflumilast 0.3 % Topical Foam	PSN	6	These highlights do not include all the information needed to use ZORYVE foam, 0.3%, safely and effectively. See full prescribing information for ZORYVE foam, 0.3%. ZORYVE ® (roflumilast) topical foam, 0.3% Initial U.S. Approval: 2011	20260130
f9e0b4a9-a227-4947-b00c-41fb18d16589	roflumilast 3 MG/ML Topical Foam	SCD	6	These highlights do not include all the information needed to use ZORYVE foam, 0.3%, safely and effectively. See full prescribing information for ZORYVE foam, 0.3%. ZORYVE ® (roflumilast) topical foam, 0.3% Initial U.S. Approval: 2011	20260130
f9e0b4a9-a227-4947-b00c-41fb18d16589	roflumilast 0.3 % Topical Foam	SY	6	These highlights do not include all the information needed to use ZORYVE foam, 0.3%, safely and effectively. See full prescribing information for ZORYVE foam, 0.3%. ZORYVE ® (roflumilast) topical foam, 0.3% Initial U.S. Approval: 2011	20260130